2005
DOI: 10.1074/jbc.m413824200
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Cloning of Mouse Type 2 and Type 3 Inositol 1,4,5-Trisphosphate Receptors and Identification of a Novel Type 2 Receptor Splice Variant

Abstract: Inositol 1,4,5-trisphosphate (IP 3 ) 1 is a second messenger generated by the phosphatidylinositol signaling cascade response to hormones, neurotransmitters, and growth factors (1) and causes Ca 2ϩ release from intracellular stores by binding to the IP 3 receptor (IP 3 R), which is an IP 3 -gated intracellular Ca 2ϩ release channel. Ca 2ϩ release in the cytoplasm occurs in complex spatial and temporal patterns, such as Ca 2ϩ waves and Ca 2ϩ oscillations, and regulates many cellular responses, including fertili… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
113
1

Year Published

2006
2006
2019
2019

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 102 publications
(124 citation statements)
references
References 72 publications
10
113
1
Order By: Relevance
“…Therefore, high concentrations of Ca 2+ prevent IP 3 binding to the receptor in this model. This specific property is consistent with the previous experimental observations in which IP 3 binding to recombinant IP 3 R1 expressed in Sf9 cells was examined under various concentrations of Ca 2+ (23,33). Our model shows that IP 3 binding prevents binding of Ca 2+ to the inactivation sites and that, re- ciprocally, Ca 2+ binding to the inactivation sites prevents IP 3 binding.…”
Section: Discussionsupporting
confidence: 79%
See 1 more Smart Citation
“…Therefore, high concentrations of Ca 2+ prevent IP 3 binding to the receptor in this model. This specific property is consistent with the previous experimental observations in which IP 3 binding to recombinant IP 3 R1 expressed in Sf9 cells was examined under various concentrations of Ca 2+ (23,33). Our model shows that IP 3 binding prevents binding of Ca 2+ to the inactivation sites and that, re- ciprocally, Ca 2+ binding to the inactivation sites prevents IP 3 binding.…”
Section: Discussionsupporting
confidence: 79%
“…S1). The apparent IP 3 binding dissociation constant of vR expressed in Sf9 cells was 21 nM (n = 2), which is consistent with that of wild-type (wt) IP 3 R1 (28.6 nM) (23). Therefore, the N-terminal fusion did not interfere with the IP 3 binding.…”
Section: Resultssupporting
confidence: 61%
“…Cells were transfected with 2 g of pHcRed1-Nuc (Clontech) alone or in combination with 10 g of pcDNA3-C2 (InsP 3 R2 cDNA in pcDNA3.1) (26). DNA was introduced into cells using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions.…”
Section: Methodsmentioning
confidence: 99%
“…The three isoforms are also differentially modulated by ATP binding, with InsP 3 R1 and InsP 3 R2 regulated by lower ATP concentrations than InsP 3 R3 (22)(23)(24). Additional functional heterogeneity is brought about by the presence of splice variants (25,26) and the possibility of heterotetrameric channels (27)(28)(29). Even though isoform-specific regulation of InsP 3 R has been well documented, the physiological consequences of this differential modulation are poorly defined.…”
mentioning
confidence: 99%
“…For instance, the inositol 1,4,5-trisphosphate receptor (IP 3 R) possesses three isoforms in mammals: Type I IP 3 R is highly expressed in cerebellar Purkinje cells of the central nervous system, whereas type II is predominantly found in cardiac ventricular myocytes (123). These isoforms not only have different subcellular distribution, which is dynamically regulated dependent on physiological conditions, but also generate different splice variants with different biophysical properties in terms of ligand binding (124). Moreover, these CaM targets are often posttranslationally modified, which may affect their ability to interact with CaM.…”
Section: Cellular Level Of Controlmentioning
confidence: 99%